Nationwide Drug Recall: Daily Medication May Result In Potentially Life-Threatening Outcome

August 30, 2018

There are new details related to a daily medication that may result in life-threatening results. According to the U.S. Food and Drug Administration (FDA), Accord Healthcare Inc. is issuing a nationwide recall due to false labeling for a commonly used medication. The drug bottle was filled with incorrect medications.

The mixed up labels may pose a risk of contracting hyperkalemia, which may increase a consumer’s potassium levels. Consequently, if contracting hyperkalemia, certain individuals may have adverse effects that could lead to a fatal outcome.

At this time, Accord Healthcare has not received any reports of adverse effects or any fatalities. We are asking our readers to check their medicine cabinets to make sure they do not have this life-threatening recalled product in their home.

Recalled Product

Accord Healthcare Inc. is recalling one lot, Lot PW05264-46632 bottles, NDC 16729-182-01, of Hydrochlorothiazide tablets USP, 12.5 mg.

100-count bottles of Hydrochlorothiazide have been found to contain 100 Spironolactone tablets USP 25 mg.

Hydrochlorothiazide tablets USP 12.5 mg are round, light orange to peach colored pills. They are biconvex tablets that are debossed with “H” on one side and “1” on the other side.

If you have this product in your home, health officials are urging consumers to return the medication to your local pharmacy or healthcare provider.

Consumers and pharmacies with questions regarding the recall can contact Accord Healthcare, Inc. by phone at 1-855-869-1081 or e-mail at Monday to Friday during business hours 8 am to 5 pm EST.

Do you or a family member take this medication? Be sure to let them know!